FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely abacavir 600 milligram and lamivudine 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 850 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine 2 milligram/1 milliliter and guanethidine monosulfate 10 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lactic acid 50 milligram/1 gram and urea 100 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely crotamiton 100 milligram/1 gram and hydrocortisone 2.5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clopamide 5 milligram and pindolol 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely conjugated estrogen 625 microgram and norgestrel 150 microgram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely latanoprost 50 microgram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dried aluminium hydroxide gel 120 milligram/1 milliliter and magnesium hydroxide 60 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and valsartan 160 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 65 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely acebutolol 200 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely colloid sulfur 80 milligram/1 gram and resorcinol 20 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 150 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ezetimibe 10 milligram and simvastatin 80 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 50 milligram and docusate sodium 60 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlordiazepoxide hydrochloride 5 milligram and clidinium bromide 2.5 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely felodipine 5 milligram and ramipril 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely adapalene 1 milligram/1 gram and benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine 70 milligram/1 gram and tetracaine 70 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 35 microgram and norethisterone 500 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cetrimide 3 milligram/1 gram and dimeticone 1000 100 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluphenazine hydrochloride 1.5 milligram and nortriptyline 30 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzoic acid 60 milligram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dihydrocodeine tartrate 20 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 5 milligram and tyrothricin 1 milligram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diphenhydramine 25 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely heparinoid 2 milligram/1 gram and lauromacrogol 400 50 milligram/1 gram conventional release rectal ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cod liver oil 114 milligram/1 gram and zinc oxide 380 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 100 milligram and ritonavir 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely erythromycin 20 milligram/1 gram and isotretinoin 500 microgram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cetrimide 150 milligram/1 milliliter and chlorhexidine gluconate 15 milligram/1 milliliter conventional release cutaneous solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous lotion Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dorzolamide (as dorzolamide hydrochloride) 20 milligram/1 milliliter and timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine 5 milligram/1 milliliter and guanethidine monosulfate 30 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and salicylic acid 30 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely domiphen bromide 500 microgram and lidocaine hydrochloride 5 milligram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metformin hydrochloride 500 milligram and rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dexamethasone 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye drops Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amitriptyline 25 milligram and perphenazine 2 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cyclizine 30 milligram and dipipanone 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely atenolol 50 milligram and chlortalidone 12.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 50 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lactic acid 40 milligram/1 gram and salicylic acid 120 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dihydrocodeine tartrate 10 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diclofenac sodium 75 milligram and misoprostol 200 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely econazole nitrate 10 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely alverine citrate 5 milligram/1 gram and Sterculia gum 620 milligram/1 gram conventional release oral granules Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely captopril 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzoyl peroxide 100 milligram/1 gram and potassium hydroxyquinoline sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ephedrine sulfate 15 milligram and theophylline 120 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release effervescent oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely bendroflumethiazide 2.5 milligram and propranolol hydrochloride 80 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzalkonium chloride 1 milligram/1 gram and dimeticone 220 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorhexidine hydrochloride 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely metoclopramide hydrochloride 5 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benzoyl peroxide 50 milligram/1 gram and clindamycin (as clindamycin phosphate) 10 milligram/1 gram conventional release cutaneous gel Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amiloride hydrochloride 5 milligram and furosemide 40 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 27 of 35 Next End

    This concept is not in any reference sets

    Back to Start